摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5,6-二氯-2-(2,2,2-三氟乙基)-1H-苯并[d]咪唑 | 882977-79-9

中文名称
5,6-二氯-2-(2,2,2-三氟乙基)-1H-苯并[d]咪唑
中文别名
——
英文名称
5,6-dichloro-2-(2,2,2-trifluoro-ethyl)-1H-benzoimidazole
英文别名
5,6-dichloro-2-(2,2,2-trifluoroethyl)-1H-benzo[d]imidazole;5,6-dichloro-2-(2,2,2-trifluoroethyl)-1H-benzimidazole
5,6-二氯-2-(2,2,2-三氟乙基)-1H-苯并[d]咪唑化学式
CAS
882977-79-9
化学式
C9H5Cl2F3N2
mdl
——
分子量
269.053
InChiKey
WTPSGAGGBLVYRS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.5
  • 重原子数:
    16
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    28.7
  • 氢给体数:
    1
  • 氢受体数:
    4

SDS

SDS:8e32d1850df0de5c558c2b88cb436f39
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Novel benzimidazole derivatives useful as selective androgen receptor modulators (SARMS)
    申请人:Ng Raymond
    公开号:US20060111402A1
    公开(公告)日:2006-05-25
    The present invention is directed to novel benzimidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
    本发明涉及新型苯并咪唑衍生物、包含它们的药物组合物及其在调节雄激素受体所致的疾病和症状中的应用。
  • Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
    申请人:Ng Raymond
    公开号:US20060116412A1
    公开(公告)日:2006-06-01
    The present invention is directed to novel benzimidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
    本发明涉及新的苯并咪唑衍生物、包含它们的药物组合物及其在治疗由雄激素受体调节的疾病和症状中的应用。
  • NOVEL BENZIMIDAZOLE DERIVATIVES USEFUL AS SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS)
    申请人:Ng Raymond
    公开号:US20080119522A1
    公开(公告)日:2008-05-22
    The present invention is directed to novel benzimidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
    本发明涉及新型苯并咪唑衍生物、包含它们的药物组合物以及它们在治疗通过雄激素受体调节的疾病和症状中的应用。
  • Benzimidazole derivatives useful as selective androgen receptor modulators (SARMS)
    申请人:Janssen Pharmaceutica N.V.
    公开号:US07348438B2
    公开(公告)日:2008-03-25
    The present invention is directed to novel benzimidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
    本发明涉及新的苯并咪唑衍生物、包含它们的制药组合物以及它们在治疗由雄激素受体调节的疾病和症状中的应用。
  • Benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
    申请人:Janssen Pharmaceutica N.V.
    公开号:US07566733B2
    公开(公告)日:2009-07-28
    The present invention is directed to novel benzimidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
    本发明涉及新的苯并咪唑衍生物,含有它们的制药组合物以及它们在治疗由雄激素受体调节的疾病和病状中的应用。
查看更多